Advertisement
Canada markets close in 3 hours 38 minutes

  • S&P/TSX

    21,778.62
    +70.18 (+0.32%)
     

  • S&P 500

    4,972.86
    -38.26 (-0.76%)
     

  • DOW

    37,861.17
    +85.79 (+0.23%)
     

  • CAD/USD

    0.7269
    +0.0006 (+0.08%)
     

  • CRUDE OIL

    83.03
    +0.30 (+0.36%)
     

  • Bitcoin CAD

    87,745.81
    +293.48 (+0.34%)
     

  • CMC Crypto 200

    1,386.15
    +73.53 (+5.83%)
     

  • GOLD FUTURES

    2,407.80
    +9.80 (+0.41%)
     

  • RUSSELL 2000

    1,946.86
    +3.90 (+0.20%)
     

  • 10-Yr Bond

    4.6080
    -0.0390 (-0.84%)
     

  • NASDAQ

    15,342.39
    -259.11 (-1.66%)
     

  • VOLATILITY

    18.61
    +0.61 (+3.39%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6826
    +0.0005 (+0.07%)
     
MARKETS LIVE BLOG:

STOCKS TRADE MIXED AFTER ISRAEL STRIKE-FUELLED TUMBLE

Apple pulls WhatsApp and Threads from China App Store

Stocks in play: Nuvo Pharmaceuticals Inc.

Baystreet.ca
·1 min read

Announced its financial and operational results for the three and 12 months ended December 31, 2019. Adjusted total revenue was $74.7 million for the year ended December 31, 2019 compared to $20.5 million for the year ended December 31, 2018. Adjusted total revenue for the three months ended December 31, 2019 was $19.6 million compared to $4.8 million for the three months ended December 31, 2018. Adjusted EBITDA was $27.2 million for the year ended December 31, 2019 compared to $(3.1) million for the year ended December 31, 2018. Adjusted EBITDA for the three months ended December 31, 2019 was $8.6 million compared to $(4.5) million for the three months ended December 31, 2018. Nuvo Pharmaceuticals Inc. shares T.NRI are trading up $0.03 at $0.98.

Read: The Top Companies Benefiting from the Global Coronavirus Outbreak